Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIDE: Thiazolidinedione Intervention With Vitamin D Evaluation
NCT00879970Phase 4Terminated
- Sponsor
- GSK
- Start
- May 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started May 2009; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00879970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879970.